← Leaderboards
Jan Gryczynski
Friends Research Institute, Inc.
$15,962,910
Attributed
$35,146,664
Total exposure
10
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $18.7M · FY2013–25$20M$15M$10M$5M$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$35,146,664 · 10
By mechanism
U01$20,259,799 · 1
R01$10,554,721 · 4
UM1$1,418,065 · 1
R33$1,130,715 · 1
R61$946,763 · 1
R21$440,000 · 1
Top collaborators
- Joshua D Lee3 shared
- Lisa A Marsch3 shared
- Sandra Ann Springer3 shared
- Karen Alexander2 shared
- Diana Howard Caldwell2 shared
- David J Farabee2 shared
- Elizabeth Needham Waddell2 shared
Most similar at Friends Research Institute, Inc.
Same institution · by research overlap
- Robert P Schwartz$28,126,650
- Courtney Nordeck$391,661
Others in their field
Top investigators on “Public Health”
- David R. Weir · University Of Michigan At Ann Arbor$416,847,438
- Jeffrey P Krischer · University Of South Florida$337,395,475
- Wafaa M. El-Sadr · Columbia University Health Sciences$336,205,398
- Elisabeth H Lyman · California St Dept Of Hlth Srvs-Sacramen$325,795,604
- Myron S Cohen · Family Health International$295,773,363
- George R Seage · Abt Associates, Inc.$292,142,010
Research focus
Public HealthProviderParticipantInnovationHealth ServicesFollow-UpPharmaceutical PreparationsResearch DesignOverdoseCommunitiesOpioid Use DisorderServicesDrug UsageClinicCaringMedicalCostAdherenceTreatment As UsualRandomizedOverdose DeathMortalityAdultNational Institute Of Drug Abuse
Grant awards (26)
âGLP-1 Outcomes with people Using Psychoactive Substances (GLOW-UPS): a multi-stage, multi-site trial among persons involved in the criminal-legal system$1,418,065
UM1 · FY2025 · DA
Implementing a patient navigation intervention across a health system to improve outcomes for patients with opioid use disorder$1,130,715
R33 · FY2025 · DA
Take-home expansion: Scope and impact study (THESIS)$633,988
R01 · FY2025 · DA · contact PI
Long-acting buprenorphine vs. naltrexone opioid treatments in CJS-involved adults$2,498,125
U01 · FY2024 · DA
Scope and impact of methadone take-home and telehealth practice changes during the COVID-19 pandemic$682,722
R01 · FY2024 · DA · contact PI
Opioid Use Disorder Treatment Linkage at STD Clinics using Buprenorphine (OUTLAST-B)$559,848
R01 · FY2024 · DA · contact PI
Implementing a patient navigation intervention across a health system to address treatment entry inequities$946,763
R61 · FY2023 · DA
Opioid Use Disorder Treatment Linkage at STD Clinics using Buprenorphine (OUTLAST-B)$688,020
R01 · FY2023 · DA · contact PI
Scope and impact of methadone take-home and telehealth practice changes during the COVID-19 pandemic$628,884
R01 · FY2023 · DA · contact PI
Scope and impact of methadone take-home and telehealth practice changes during the COVID-19 pandemic$537,775
R01 · FY2022 · DA · contact PI
Opioid Use Disorder Treatment Linkage at STD Clinics using Buprenorphine (OUTLAST-B)$691,445
R01 · FY2021 · DA · contact PI
Opioid Use Disorder Treatment Linkage at STD Clinics using Buprenorphine (OUTLAST-B)$694,522
R01 · FY2020 · DA · contact PI
People Preferring Fentanyl (PPF): Characteristics, Outcomes, and Perspectives$200,000
R21 · FY2020 · DA · contact PI
Long-acting buprenorphine vs. naltrexone opioid treatments in CJS-involved adults$17,761,674
U01 · FY2019 · DA
Opioid Use Disorder Treatment Linkage at STD Clinics using Buprenorphine (OUTLAST-B)$707,730
R01 · FY2019 · DA · contact PI
People Preferring Fentanyl (PPF): Characteristics, Outcomes, and Perspectives$240,000
R21 · FY2019 · DA · contact PI
Navigation Services to Avoid Rehospitalization (NavSTAR) among substance abusers$526,567
R01 · FY2018 · DA · contact PI
Navigation Services to Avoid Rehospitalization (NavSTAR) among substance abusers$620,178
R01 · FY2017 · DA · contact PI
A randomized clinical trial of SBIRT services in school-based health centers$572,825
R01 · FY2017 · DA · contact PI
Navigation Services to Avoid Rehospitalization (NavSTAR) among substance abusers$613,219
R01 · FY2016 · DA · contact PI
A randomized clinical trial of SBIRT services in school-based health centers$607,946
R01 · FY2016 · DA · contact PI
A randomized clinical trial of SBIRT services in school-based health centers$617,285
R01 · FY2015 · DA · contact PI
Navigation Services to Avoid Rehospitalization (NavSTAR) among substance abusers$592,474
R01 · FY2015 · DA · contact PI
A randomized clinical trial of SBIRT services in school-based health centers$579,293
R01 · FY2014 · DA · contact PI
Performance Improvement Technology in Urban Native American Health Organizations$200,000
R43 · FY2014 · MD
Performance Improvement Technology in Urban Native American Health Organizations$196,601
R43 · FY2013 · MD